definiens: as that term is defined in the Private Securities LitigationReform Act of 1995, regarding the research, development and commercialization of pharmaceutical products . Suchforward - looking statements are based on current expectations and involve inherent risks and uncertainties, includingfactors that could delay, divert or change any of them, and could cause actual outcomes and results to differmaterially from current expectations . No forward - looking statement can be guaranteed . Among other risks, there canbe no guarantee that the compound described in this release will move from early stage development into fullproduct development, that clinical trials of this compound will support a regulatory filing, or that the compound willreceive regulatory approval or become a commercially successful product . Nor is there any guarantee that thetransaction described in this release will receive the necessary regulatory approvals to close . Forward - lookingstatements in the press release should be evaluated together with the many uncertainties that can effect the fulldevelopment of this pharmaceutical . [COMPANY] undertakes no obligation to publicly update any forward - lookingstatement, whether as a result of new information, future events, or otherwise . Contact us atakodsi@serenitypharma.com or 917 - 548 - 8181